Navigation Links
Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
Date:4/8/2008

- Agreement includes upfront, milestone and royalty payments on future

sales -

TORONTO, April 8 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. ("Lorus") (TSX: LOR; AMEX: LRP), a biopharmaceutical company dedicated to the research and development of pharmaceutical products and technologies for the management of cancer, announced today that its subsidiary GeneSense Technologies, Inc. ("GeneSense") has signed an exclusive multinational license agreement with Zor Pharmaceuticals LLC formed as a subsidiary of Zoticon Bioventures Inc. ("Zoticon"), a research-driven biopharmaceutical group, to further develop and commercialize Virulizin(R) for human therapeutic applications. The initial clinical development of Virulizin(R) under the agreement will be in advanced pancreatic cancer.

Under the terms of the agreement, GeneSense will be entitled to receive payments in excess of US$10 million upon achievement of various milestone events and royalties that vary from 10-20% depending on achieving of sales of Virulizin(R) and subject to certain other adjustments. In addition, a wholly owned subsidiary of Lorus, Pharma Immune Inc. ("Pharma Immune") will receive 25% of the initial equity in Zor Pharmaceuticals. Pharma Immune's equity will not be subject to dilution on the first US$5 million of financing in Zor Pharmaceuticals. Thereafter, Pharma Immune has, at its option, a right to participate in any additional financings to maintain its ownership level. In addition, GeneSense has entered into a Service Agreement with Zor Pharmaceuticals to assist in the transfer of knowledge and establish a strong foundation for moving forward with the development program for Virulizin.

Zor Pharmaceuticals will be responsible for the cost of all the clinical development, regulatory submissions and commercialization of Virulizin(R) in North and South America and Europe. GeneSense will retain rights in all other countries, including Jap
'/>"/>

SOURCE Lorus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
2. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
7. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
10. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
11. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2014)... Sept. 26, 2014 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic stem cell ... will hold its 2014 annual general meeting of shareholders at its ... China Tower, 1 Garden Road, Central, Hong Kong ... (8:00 a.m. U.S. Eastern Time on December 11, 2014). ...
(Date:9/26/2014)... September 26, 2014 Molecular Biology ... the cell for the regulation of cellular activity and ... interactions between genes and with its environment within the ... of new and novel therapeutic methodologies for the diagnosis, ... , On this occasion, Dr. Srinubabu Gedela, MD of ...
(Date:9/26/2014)... “Inflamax’s Clinical Data Management group is a ... this allows us to support our group in maintaining ... Johnson, Director of Data Management at Inflamax. “Being ... our Clinical Data Managers have been certified by passing ... to offering only the best services to our clients, ...
(Date:9/25/2014)... implicated in several cancers appears to play a pivotal role ... to a new study by NYU Langone Medical Center scientists. ... . , Stem cells are the perpetual adolescents of the ... can be programmed to differentiate into any mature cell type, ... understanding of their biology, however, is needed. ...
Breaking Biology Technology:China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 3NYU Langone scientists identify key factor that maintains stem cell identity 2
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) ... research group at The Institute of Cancer Research, ... combination treatment schedules,of reovirus and radiation in human ... The paper, entitled "Enhanced In vitro and In ...
... environment and holding it indefinitely in molecular-sized containers has been ... say it represents a novel method of gas storage that ... safely and efficiently. , This is a proof of concept ... just improving on a method that already exists, said U ...
... the economy is not,only heading towards a recession but ... during January. However, biotech held steady,with the Burrill Biotech ... posted a January loss of 9.9%, and the Dow, ... ride out extremely volatile capital,markets with less damage because ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy 2Rounding up gases, nano-style 2January Market Jitters Fails to Derail Biotech 2January Market Jitters Fails to Derail Biotech 3January Market Jitters Fails to Derail Biotech 4
(Date:9/29/2014)... Advocacy Awards will honor ... medical progress to improve the health and economic ... place on Wednesday, March 11, 2015, at the ... The 2015 Advocacy Award winners are ABC,s "Good ... of the Milken Institute and FasterCures; Dr. Kenneth ...
(Date:9/29/2014)... Energy Joint Genome Institute (DOE JGI), a DOE ... 32 new projects have been selected for the ... lakes to Caribbean waters, and from plant root ... in forested watersheds, the CSP 2015 projects portfolio ... be extracted. , "These projects catalyze JGI,s ...
(Date:9/29/2014)... WASHINGTON, Sept. 29, 2014 Oktoberfest is ... nothing worse than reaching for a cold ... your beer,s been skunked: chemicals have reacted ... bitter taste. This week, Reactions explains why ... do to keep your brews from going ...
Breaking Biology News(10 mins):Research!America to honor leaders in medical and health research advocacy 2Research!America to honor leaders in medical and health research advocacy 3Research!America to honor leaders in medical and health research advocacy 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 22015 DOE JGI's science portfolio delves deeper into the Earth's data mine 32015 DOE JGI's science portfolio delves deeper into the Earth's data mine 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 52015 DOE JGI's science portfolio delves deeper into the Earth's data mine 62015 DOE JGI's science portfolio delves deeper into the Earth's data mine 72015 DOE JGI's science portfolio delves deeper into the Earth's data mine 82015 DOE JGI's science portfolio delves deeper into the Earth's data mine 9
... by the University of Zaragoza (UNIZAR) started to carry out ... then they have focused on analysing the fossil remains of ... the Cantabrian region over the past 41,000 years, at the ... conservation status of the fossils have enabled the researchers to ...
... in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2009-06/kcl-nss060209.php,">Chinese . Flooding is ... globe. It is the worst natural disaster in the ... figure is expected to increase to 3.5 billion over ... that took place in China over the past decade ...
... In recent years, obesity has taken on epidemic proportions ... early death and rising health care costs. According to ... a quarter of all American adults and more than ... While recent research advances and treatment ...
Cached Biology News:Cantabrian cornice has experienced seven cooling and warming phases over past 41,000 years 2Next-generation software system for flood warning and risk analysis to be developed 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 3
... new MALDI O-TOF creates a new category ... orthogonal platform that has been licensed to ... of Manitoba. , As the first single ... and collisional cooling, the prOTOF 2000 represents ...
Rat Dermal Fibroblasts (RDF) (>500,000 cells)...
...
... The NeuroLog System is a compact, versatile & ... variety of purposes including: Intracellular, Extracellular, Transducer ... The NeuroLog Case & Power Supply unit ... Modules are not only powered by this ...
Biology Products: